NDC 0409-1808 - Novocain
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0409-1808
- Package NDCs from labels
- 0409-1808-02, 0409-1808-06
- Manufacturer
- Hospira, Inc.
- Effective date
- 2007-04-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| NOVOCAIN ® PROCAINE HYDROCHLORIDE INJECTION, USP | Hospira, Inc. | 2007-04-16 | Human prescription drug label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0409-1808-02 | Novocain | 5 in 1 CONTAINER | INJECTION, SOLUTION | 5 | 1 | |
| 0409-1808-02 | Novocain | 40 in 1 CASE | INJECTION, SOLUTION | 40 | 1 | |
| 0409-1808-06 | Novocain | 50 in 1 TRAY | INJECTION, SOLUTION | 50 | 1 | |
| 0409-1808-06 | Novocain | 10 in 1 CASE | INJECTION, SOLUTION | 10 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Procaine Hydrochloride | ACTIVE INGREDIENT | 95URV01IDQ | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Procaine | ACTIVE MOIETY | 4Z8Y51M438 | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Acetone Sodium Bisulfite | INACTIVE INGREDIENT | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | ||
| Chlorobutanol | INACTIVE INGREDIENT | HM4YQM8WRC | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Hydrochloric Acid | INACTIVE INGREDIENT | QTT17582CB | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Sodium Chloride | INACTIVE INGREDIENT | 451W47IQ8X | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Sodium Hydroxide | INACTIVE INGREDIENT | 55X04QC32I | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| sodium chloride | SODIUM CHLORIDE | Medefil, Inc. | d1468c0f-dd4f-4d38-a84c-c1d110303965 | 2026-02-26 | Warnings, Adverse reactions | sodium chloride |
| VinCRIStine Sulfate | VINCRISTINE SULFATE | Hospira, Inc. | b22e4c8e-dbe1-4d4b-a026-e1812974071c | 2026-02-17 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Magnesium Sulfate | MAGNESIUM SULFATE | Hospira, Inc. | e175d329-315f-4f3b-bb4c-06ad4e042967 | 2026-02-12 | Warnings, Adverse reactions | Hospira, Inc. |
| Hydromorphone Hydrochloride | HYDROMORPHONE HYDROCHLORIDE | Hospira, Inc. | f9ca2ef5-46d8-475a-a26e-f7c8becd6db7 | 2026-02-04 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Calcium Chloride | CALCIUM CHLORIDE | Hospira, Inc. | c4c65e48-85f8-4dcf-6281-06e40959cc79 | 2026-02-02 | Warnings, Adverse reactions | Hospira, Inc. |
| Sodium Chloride | SODIUM CHLORIDE | Nephron Pharmaceuticals Corporation | a4edf2d5-a9ff-30d4-e053-2995a90a5650 | 2026-01-26 | Warnings, Adverse reactions | Sodium Chloride |
| Sodium Chloride | SODIUM CHLORIDE | ProPharma Distribution | 48d73434-e65b-dc98-e063-6294a90affa2 | 2026-01-20 | Adverse reactions | Sodium Chloride |
| Sodium chloride | SODIUM CHLORIDE | Fresenius Kabi USA, LLC | d98bf9f7-30ec-4927-a577-cabad192cb18 | 2026-01-19 | Warnings, Adverse reactions | Sodium chloride |
| Sodium chloride | SODIUM CHLORIDE | BECTON DICKINSON AND COMPANY | d39b7307-df67-4e68-acb0-2eda5dc61215 | 2026-01-07 | Warnings, Adverse reactions | Sodium chloride |
| Buprenorphine Hydrochloride | BUPRENORPHINE HYDROCHLORIDE | Hospira, Inc. | 23aa1bb3-cecf-4e62-29bb-48488bb66fc3 | 2025-12-31 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Morphine Sulfate | MORPHINE SULFATE | Hospira, Inc. | be420e8b-bcb0-49b5-bb4d-1df8b9959809 | 2025-12-31 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Morphine Sulfate | MORPHINE SULFATE | Hospira, Inc. | ee8057d1-ed12-4e18-9efa-d83504abf612 | 2025-12-31 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Hydromorphone Hydrochloride | HYDROMORPHONE HYDROCHLORIDE | Hospira, Inc. | e9c9ef18-7dfc-4322-b2fc-29b934c30f8b | 2025-12-31 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Nalbuphine Hydrochloride | NALBUPHINE HYDROCHLORIDE | Hospira, Inc. | 6025e8d4-5083-4c3a-58a0-050e7b0b6150 | 2025-12-31 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| VinCRIStine Sulfate | VINCRISTINE SULFATE | Hospira, Inc. | 49596de6-ab18-49d1-9e5b-30968fc21c36 | 2025-12-30 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Sodium Chloride | SODIUM CHLORIDE | ProPharma Distribution | 3f79fb8b-d0e8-db2a-e063-6394a90ac136 | 2025-12-18 | Warnings, Adverse reactions | Sodium Chloride |
| Sodium Chloride | SODIUM CHLORIDE | SOLA Pharmaceuticals, LLC | 4d0bfd28-460a-48ba-bd17-cf75e56d62f4 | 2025-12-09 | Warnings, Adverse reactions | Sodium Chloride |
| Regadenoson | REGADENOSON | Hospira, Inc. | 0e3f080d-b1fb-47ed-8cd3-90a4206fa704 | 2025-12-08 | Warnings, Adverse reactions | Hospira, Inc. |
| Ondansetron | ONDANSETRON | Hospira, Inc. | e0862c02-781f-4b10-ae50-9c9c4ca26f6d | 2025-12-01 | Warnings, Adverse reactions | Hospira, Inc. |
| Metronidazole | METRONIDAZOLE | Hospira, Inc. | 49360d6f-c8b3-420e-af75-154cf7b05255 | 2025-11-19 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.